Skip to main content
SpringerLink
Log in

The Impact of Lifestyle Modification on Erectile Dysfunction

  • Chapter
Management of Sexual Dysfunction in Men and Women

  • 2176 Accesses

Abstract

While it has been difficult to establish causality, strong associations between erectile dysfunction (ED) and lifestyle diseases such as cardiovascular disease (CVD), diabetes mellitus, hypertension, obesity/metabolic syndrome, smoking, and psychosocial factors have been identified. The pathophysiology behind the associations is thought to center around endothelial dysfunction. Similar to the beneficial effects noted in CVD, studies have suggested a beneficial impact of lifestyle modifications on improving ED and underline the importance of encouraging a healthy lifestyle in the management of ED.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol. 1994;151(1):54–61.

    CAS  PubMed  Google Scholar 

  2. Weber MF, Smith DP, O’Connell DL, Patel MI, de Souza PL, Sitas F, et al. Risk factors for erectile dysfunction in a cohort of 108 477 Australian men. Med J Aust. 2013;199(2):107–11.

    Article  PubMed  Google Scholar 

  3. Montorsi F, Briganti A, Salonia A, Rigatti P, Margonato A, Macchi A, et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol. 2003;44(3):360–4.

    Article  PubMed  Google Scholar 

  4. Vlachopoulos C, Rokkas K, Ioakemidis N, Aggeli C, Michaelides A, Roussakis G, et al. Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study. Eur Urol. 2005;48(6):996–1002.

    Article  PubMed  Google Scholar 

  5. Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, Aznaouridis KA, Stefanadis CI. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circ Cardiovasc Qual Outcomes. 2013;6(1):99–109.

    Article  PubMed  Google Scholar 

  6. Dong JY, Zhang YH, Qin LQ. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2011;58(13):1378–85.

    Article  PubMed  Google Scholar 

  7. Gandaglia G, Briganti A, Jackson G, Kloner RA, Montorsi F, Montorsi P, et al. A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur Urol. 2013 (in press).

    Google Scholar 

  8. Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? J Urol. 2000;56(2):302–6.

    Article  CAS  Google Scholar 

  9. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. A prospective study of risk factors for erectile dysfunction. J Urol. 2006;176(1):217–21.

    Article  PubMed  Google Scholar 

  10. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D’Andrea F, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291(24):2978–84.

    Article  CAS  PubMed  Google Scholar 

  11. Lamina S, Okoye CG, Dagogo TT. Therapeutic effect of an interval exercise training program in the management of erectile dysfunction in hypertensive patients. J Clin Hypertens (Greenwich). 2009;11(3):125–9.

    Article  Google Scholar 

  12. Cheng JY, Ng EM, Ko JS, Chen RY. Physical activity and erectile dysfunction: meta-analysis of population-based studies. Int J Impot Res. 2007;19(3):245–52.

    Article  CAS  PubMed  Google Scholar 

  13. Vlachopoulos C, Rokkas K, Ioakeimidis N, Stefanadis C. Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. Eur Urol. 2007;52(6):1590–600.

    Article  CAS  PubMed  Google Scholar 

  14. Trepels T, Zeiher AM, Fichtlscherer S. The endothelium and inflammation. Endothelium. 2006;13(6):423–9.

    Article  PubMed  Google Scholar 

  15. Yao F, Huang Y, Zhang Y, Dong Y, Ma H, Deng C, et al. Subclinical endothelial dysfunction and low-grade inflammation play roles in the development of erectile dysfunction in young men with low risk of coronary heart disease. Int J Androl. 2012;35(5):653–9.

    Article  CAS  PubMed  Google Scholar 

  16. Billups KL, Kaiser DR, Kelly AS, Wetterling RA, Tsai MY, Hanson N, et al. Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction. Int J Impot Res. 2003;15(4):231–6.

    Article  CAS  PubMed  Google Scholar 

  17. Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med. 2009;6(5):1232–47.

    Article  PubMed  Google Scholar 

  18. Bacon CG, Hu FB, Giovannucci E, Glasser DB, Mittleman MA, Rimm EB. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care. 2002;25(8):1458–63.

    Article  PubMed  Google Scholar 

  19. Kalter-Leibovici O, Wainstein J, Ziv A, Harman-Bohem I, Murad H, Raz I, Israel Diabetes Research Group (IDRG) Investigators. Clinical, socioeconomic, and lifestyle parameters associated with erectile dysfunction among diabetic men. Diabetes Care. 2005;28(7):1739–44.

    Article  PubMed  Google Scholar 

  20. Wessells H, Penson DF, Cleary P, Rutledge BN, Lachin JM, McVary KT, Schade DS, Sarma AV, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes. J Urol. 2011;185(5):1828–34.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Romeo JH, Seftel AD, Madhun ZT, Aron DC. Sexual function in men with diabetes type 2: association with glycemic control. J Urol. 2000;163(3):788–91.

    Article  CAS  PubMed  Google Scholar 

  22. Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007;30(4):911–7.

    Article  CAS  PubMed  Google Scholar 

  23. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120(2):151–7.

    Article  PubMed  Google Scholar 

  24. Cordero A, Bertomeu-Martinez V, Mazon P, Facila L, Gonzalez-Juanatey JR. Erectile dysfunction may improve by blood pressure control in patients with high-risk hypertension. Postgrad Med. 2010;122(6):51–6.

    Article  PubMed  Google Scholar 

  25. Cordero A, Bertomeu-Martinez V, Mazon P, Facila L, Bertomeu-Gonzalez V, Conthe P, et al. Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents. Cardiovasc Ther. 2010;28(1):15–22.

    Article  CAS  PubMed  Google Scholar 

  26. Lue T. Physiology of penile erection and pathophysiology of erectile dysfunction. In: Wein A, editor. Campbell-Walsh urology. 10th ed. Philadelphia: Elsevier-Saunders; 2012. p. 688–720.

    Chapter  Google Scholar 

  27. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med. 2000;30(4):328–38.

    Article  CAS  PubMed  Google Scholar 

  28. Mannino DM, Klevens RM, Flanders WD. Cigarette smoking: an independent risk factor for impotence? Am J Epidemiol. 1994;140(11):1003–8.

    CAS  PubMed  Google Scholar 

  29. Cao S, Yin X, Wang Y, Zhou H, Song F, Lu Z. Smoking and risk of erectile dysfunction: systematic review of observational studies with meta-analysis. PLoS One. 2013;8(4), e60443.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Pourmand G, Alidaee MR, Rasuli S, Maleki A, Mehrsai A. Do cigarette smokers with erectile dysfunction benefit from stopping?: a prospective study. BJU Int. 2004;94(9):1310–3.

    Article  PubMed  Google Scholar 

  31. Harte CB, Meston CM. Association between smoking cessation and sexual health in men. BJU Int. 2012;109(6):888–96.

    Article  PubMed  Google Scholar 

  32. Tostes RC, Carneiro FS, Lee AJ, Giachini FR, Leite R, Osawa Y, et al. Cigarette smoking and erectile dysfunction: focus on NO bioavailability and ROS generation. J Sex Med. 2008;5(6):1284–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Melman A, Tiefer L, Pedersen R. Evaluation of first 406 patients in urology department based center for male sexual dysfunction. Urology. 1988;32(1):6–10.

    Article  CAS  PubMed  Google Scholar 

  34. McCabe M, Althof SE, Assalian P, Chevret-Measson M, Leiblum SR, Simonelli C, Wylie K. Psychological and interpersonal dimensions of sexual function and dysfunctions. J Sex Med. 2010;7(1):327–36.

    Article  PubMed  Google Scholar 

  35. Shiri R, Koskimaki J, Tammela T, Hakkinen J, Auvinen A, Hakama M. Bidirectional relationship between depression and erectile dysfunction. J Urol. 2007;177:669–73.

    Article  PubMed  Google Scholar 

  36. Montejo-gonzàlez AL, Llorca G, Izquierdo JA, Ledesma A, Bousono M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, De LA Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E. Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther. 1997;23(3):176–94.

    Article  PubMed  Google Scholar 

  37. Wylie K. Treatment outcome of brief couple therapy in psychogenic male erectile disorder. Arch Sex Behav. 1997;26(5):527–45.

    Article  CAS  PubMed  Google Scholar 

  38. Melnik T, Soares BG, Nasello AG. The effectiveness of psychological interventions of the treatment of erectile dysfunction: systematic review and meta-analysis, including comparisons to sildenafil treatment, intracavernosal injection, and vacuum devices. J Sex Med. 2008;5(11):2562–74.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Urology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada

    Phil Bach M.D.

  2. Department of Urology, Feinberg School of Medicine, Northwestern University, Galter Pavilion, Suite 20-150, 675 N Saint Clair, Chicago, IL, 60611, USA

    Robert E. Brannigan M.D.

Authors
  1. Phil Bach M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert E. Brannigan M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert E. Brannigan M.D. .

Editor information

Editors and Affiliations

  1. Chief, Division of Male Reproductive Medicine and Surgery; Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA

    Larry I. Lipshultz

  2. Assistant Professor; Division of Male Reproductive Medicine and Surgery; Center for Reproductive Medicine; Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA

    Alexander W. Pastuszak

  3. Department of Obstetrics and Gynecology; George Washington University; School of Medicine and Health Sciences, The Center for Vulvovaginal Disorders, Washington, District of Columbia, USA

    Andrew T. Goldstein

  4. Psychiatric Center Copenhagen; Institute of Clinical Medicine; University of Copenhagen, Sexological Clinic, Copenhagen, Denmark

    Annamaria Giraldi

  5. Weill Medical College Cornell University; Co-Director, Human Sexuality Program; The New York Presbyterian Hospital; Founder, MAP Education and Research Fund, Clinical Professor of Psychiatry, Reproductive Medicine and Urology, NEW YORK, New York, USA

    Michael A. Perelman

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bach, P., Brannigan, R.E. (2016). The Impact of Lifestyle Modification on Erectile Dysfunction. In: Lipshultz, L., Pastuszak, A., Goldstein, A., Giraldi, A., Perelman, M. (eds) Management of Sexual Dysfunction in Men and Women. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3100-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3100-2_8

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3099-9

  • Online ISBN: 978-1-4939-3100-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation